EUVIMEDEUVIMED entdecken
Crossref

Disorders of gut–brain interaction in Aotearoa New Zealand: a long-standing evidence gap with unmeasured health and economic consequences

Simone Bayer, Jody Miller, Nathan Berg

New Zealand Medical Journal · 20.11.2026 · 139 (1646) · 97-102

DOI: 10.26635/6965.7608 ↗

Kurz gefasst

Fachartikel in der Zeitschrift New Zealand Medical Journal, online erschienen am 20.11.2026. Verfasst von Simone Bayer und 2 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

aim: The aim of this viewpoint was to summarise evidence regarding prevalence and economic burden of disorders of gut–brain interaction (DGBI), e.g., irritable bowel syndrome (IBS), in Aotearoa New Zealand and estimate their likely scale using comparable-country data. methods: We conducted a scoping review of Ovid Embase and PubMed (searched on 10 December 2025) for studies reporting adult DGBI prevalence or economic burden in New Zealand, the United Kingdom (UK) and Australia. New Zealand data were included regardless of diagnostic criteria; UK and Australian data were restricted to Rome IV studies. results: Only four New Zealand prevalence studies were identified, the most recent published in 2002; no study has reported DGBI prevalence in Māori or Pacific people. Two small, industry-linked New Zealand cost studies were identified. UK and Australian Rome IV data indicate adult DGBI prevalence of approximately 37%, with significant healthcare expenditure and productivity loss. Extrapolating UK mean direct costs per IBS patient to one-third of New Zealand’s adults, direct healthcare utilisation costs are approximately NZ$1.6 billion annually, with total costs approaching 1% of gross domestic product. conclusion: New Zealand lacks contemporary prevalence data, equity-specific data for Māori and credible cost-of-illness estimates for DGBI. Extrapolation from comparable countries suggests the true burden is large and current research and clinical investment are extraordinarily mismatched to it.

Zitieren

APA

Bayer, S., Miller, J., & Berg, N. (2026). Disorders of gut–brain interaction in Aotearoa New Zealand: a long-standing evidence gap with unmeasured health and economic consequences. New Zealand Medical Journal, 139(1646), 97-102. https://doi.org/10.26635/6965.7608

Vancouver

Bayer S, Miller J, Berg N. Disorders of gut–brain interaction in Aotearoa New Zealand: a long-standing evidence gap with unmeasured health and economic consequences. New Zealand Medical Journal. 2026;139(1646):97-102. doi:10.26635/6965.7608

BibTeX
@article{Bayer2026,
  author = {Bayer, Simone and Miller, Jody and Berg, Nathan},
  title = {Disorders of gut–brain interaction in Aotearoa New Zealand: a long-standing evidence gap with unmeasured health and economic consequences},
  journal = {New Zealand Medical Journal},
  year = {2026},
  volume = {139},
  number = {1646},
  pages = {97--102},
  doi = {10.26635/6965.7608}
}
Kostenlos starten →